Please wait a minute...
 Home  About the Journal Editorial Board Aims & Scope Peer Review Policy Subscription Contact us
 
Early Edition  //  Current Issue  //  Open Special Issues  //  Archives  //  Most Read  //  Most Downloaded  //  Most Cited
Aging and disease
Orginal Article |
A Review of Exercise as Medicine in Cardiovascular Disease: Pathology and Mechanism
Piotr Gronek1,*, Dariusz Wielinski2, Piotr Cyganski3, Andrzej Rynkiewicz3, Adam Zając4, Adam Maszczyk5, Joanna Gronek1, Robert Podstawski6, Wojciech Czarny7, Stefan Balko8, Cain CT. Clark9, Roman Celka1
1Laboratory of Genetics, Department of Dance and Gymnastics, Poznań University of Physical Education, Poznań, Poland.
2 Department of Anthropology and Biometry, Poznań University of Physical Education, Poznań, Poland. 3Department of Cardiology and Cardiosurgery, Ist Cardiology Clinic, City Hospital in Olsztyn, University of Warmia and Mazury in Olsztyn, Poland.
4Department of Sports Training, The Jerzy Kukuczka Academy of Physical Education in Katowice, Katowice, Poland.
5Department of Methodology and Statistics, The Jerzy Kukuczka Academy of Physical Education in Katowice, Katowice, Poland.
6Department of Physical Education and Sport, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland.
7Department of Human Sciences, University of Rzeszow, Rzeszów, Poland. 8Department of Physical Education and Sport, Faculty of Education, Jan Evangelista Purkyne University in Usti nad Labem, Czech Republic.
9School of Life Sciences, Coventry University, Coventry, CV1 5FB, United Kingdom.
Download: PDF(489 KB)   HTML
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks    
Abstract  Background:

Physical inactivity and resultant lower energy expenditure contribute unequivocally to cardiovascular diseases, such as coronary artery disease and stroke, which are considered major causes of disability and mortality worldwide.

Aim:

The aim of the study was to investigate the influence of physical activity (PA) and exercise on different aspects of health - genetics, endothelium function, blood pressure, lipid concentrations, glucose intolerance, thrombosis, and self - satisfaction. Materials and

Methods:

In this article, we conducted a narrative review of the influence PA and exercise have on the cardiovascular system, risk factors of cardiovascular diseases, searching the online databases; Web of Science, PubMed and Google Scholar, and, subsequently, discuss possible mechanisms of this action.

Results

and Discussion: Based on our narrative review of literature, discussed the effects of PA on telomere length, nitric oxide synthesis, thrombosis risk, blood pressure, serum glucose, cholesterol and triglycerides levels, and indicated possible mechanisms by which physical training may lead to improvement in chronic cardiovascular diseases.

Conclusion:

PA is effective for the improvement of exercise tolerance, lipid concentrations, blood pressure, it may also reduce the serum glucose level and risk of thrombosis, thus should be advocated concomitant to, or in some cases instead of, traditional drug-therapy.

Keywords physical activity      longevity      cardiovascular disease      public health problem      aging     
Corresponding Authors: Piotr Gronek   
Just Accepted Date: 02 July 2019  
Service
E-mail this article
E-mail Alert
RSS
Articles by authors
Piotr Gronek
Dariusz Wielinski
Piotr Cyganski
Andrzej Rynkiewicz
Adam Zając
Adam Maszczyk
Joanna Gronek
Robert Podstawski
Wojciech Czarny
Stefan Balko
Cain CT. Clark
Roman Celka
Cite this article:   
Piotr Gronek,Dariusz Wielinski,Piotr Cyganski, et al. A Review of Exercise as Medicine in Cardiovascular Disease: Pathology and Mechanism[J]. Aging and disease, 10.14336/AD.2019.0516
URL:  
http://www.aginganddisease.org/EN/10.14336/AD.2019.0516     OR     http://www.aginganddisease.org/EN/Y/V/I/0
ParticipantsType of ExerciseInfluence on Telomere LengthRef
123 males (56 healthy non - maraton runners, 67 ultra - maraton runners)Ultra - maraton running, exercise 40 - 100 km/week, ?2 yearsLonger leukocyte telomere length in runners vs. non - runners[27]
62 adults (20 athletes, 42 sedentary controls)Endurance exerciseLonger salivary telomere length in endurance athletes vs. sedentary control[28]
2401 white twin adultsSelf - reported physical activity (4 groups based on physical activity levels)Longer leukocyte telomere length with increasing exercise level[29]
69 healthy adultsVarious aerobic exercise (divided into quartiles based on exercise energy
Expenditure: 0-990, 991-2340, 2341-3540, and 93541 kcal/wk)
Longer leukocyte telomere length in 2nd quartile vs. 1st and 4th quartile. Same telomere length in 2nd quartile vs. 3rd quartile.[30]
44 healthy postmenopausal women (21 sedentary subjects, 23 habitual exercise participants)Aerobic and resistance exercise for 60± minutes, >3 times per week, for > 12 monthsLonger leukocyte telomere length in aerobic and resistance exercise participants vs sedentary subjects.[31]
14 healthy adults (7 non - lifters, 7 power lifters)Power lifting; 8±3 yearsLonger skeletal muscle telomere length in power lifters vs non - lifters.[32]
20 young and older men (10 medium activity level, 10 endurance athletes).Endurance exercise (long distance skiing & track running competitions); Medium activity (moderately physically active)Longer skeletal muscle telomere length in older athletes vs older medium - activity individuals. Same telomere length in young athletes vs young medium - activity individuals.[33]
7,813 adult womenEight possible physical activitiesIncrease in leukocyte telomere length (0.10-SD) was observed when comparing the most to the least active women.[34]
944 adults with stable coronary heart diseaseSelf - reported physical activityShorter telomere length
associated with physical activity, but not after multivariate adjustment.
[35]
32 adults (15 sedentary healthy subjects, 17 marathon runners)Marathon running, 32±9 miles/week, 14±11 yearsSame leukocyte telomere length in runners vs. sedentary subjects[36]
37 adults (19 sedentary subjects, 18 endurance runners)Endurance running: 40 km/week, ?7 yearsSame (skeletal muscle) telomere length in runners vs. sedentary individuals. Shorter telomere length in subjects with longer exercise history vs. shorter training history. Shorter telomere length in subjects with greater volume of training hours vs. lower volume of training hours.[37]
25 healthy young and 32 older adultsVigorous aerobic exercise ?5 days/week, >45 min/Day, ?5 yearsSame leukocyte telomere length in older athletes vs. older sedentary subjects.[38]
Table 1  Effect of exercise on telomere length.
Figure 1.  Summary of main pathways effect of aerobic exercise.
[1] Cordain L, Gotshall RW, Eaton SB, Eaton SB, 3rd (1998). Physical activity, energy expenditure and fitness: an evolutionary perspective. Int J Sports Med, 19: 328-335.
[2] Vigilant L, Stoneking M, Harpending H, Hawkes K, Wilson AC (1991). African populations and the evolution of human mitochondrial DNA. Science, 253(5027): 1503-7.
[3] O’Keefe JH, Vogel R, Lavie CJ, Cordain L (2011). Exercise like a hunter - gatherer: a prescription for organic physical fitness. Prog Cardiovasc Dis, 53: 471-479.
[4] Fluck M (2006). Functional, structural and molecular plasticity of mammalian skeletal muscle in response to exercise stimuli. J Exp Biol, 209:2239-48.
[5] Booth FW, Laye MJ, Lees SJ, et al (2008). Reduced physical activity and risk of chronic disease: the biology behind the consequences. Eur J Appl Physiol, 102: 381-390.
[6] Booth FW, Lees SJ (2007). Fundamental questions about genes, inactivity, and chronic diseases. Physiol Genomics, 28: 146-157.
[7] Cordain L, Friel J (2005). The Paleo diet for athletes, Anutritional formula for peak athletic performance. New York: Rodale Books, 288.
[8] Babizhayev MA, Savelyeva EL, Moskvina SN, Yegorov YE (2011). Telomere length is a biomarker of cumulative oxidative stress, biologic age, and an independent predictor of survival and therapeutic treatment requirement associated with smoking behavior. Am J Therapeutics, 18(6):e209-26.
[9] Shammas MA (2011). Telomeres, lifestyle, cancer, and aging. Curr Opin Clin Nutr Met Care, 14(1):28-34.
[10] Kirkevold M (1997). Integrative nursing research--an important strategy to further the development of nursing science and nursing practice. J Adv Nurs, 25(5):977-84.
[11] Mays N, Pope C, Popay J (2005). Systematically reviewing qualitative and quantitative evidence to inform management and policy-making in the health field. J Health Serv Res Policy, Suppl 1:6-20.
[12] Greenhalgh T, Thorne S, Malterud K (2018). Time to challenge the spurious hierarchy of systematic over narrative reviews? Eur J Clin Invest, 48(6):e12931.
[13] Greenhalgh T, Robert G, Macfarlane F, Bate P, Kyriakidou O, Peacock R (2005). Storylines of research in diffusion of innovation: a meta-narrative approach to systematic review. Soc Sci Med, 61(2):417-30.
[14] Blasco MA (2005). Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet, 6(8): 611-622.
[15] Muezzinler A, Zaineddin AK, Brenner H (2013). A systematic review of leukocyte telomere length and age in adults. Ageing Res Rev, 12: 509-519.
[16] Aviv A (2004). Telomeres and human aging: facts and fibs. Sci Aging Knowledge Environ, 51: 43.
[17] Oeseburg H, de Boer RA, van Gilst WH, van der Harst P (2010). Telomere biology in healthy aging and disease. Pflugers Arch, 459: 259-268.
[18] Okuda K, Bardeguez A, Gardner JP, Rodriguez P, Ganesh V, Kimura M, Skurnick J, Awad G, Aviv A (2002). Telomere length in the newborn. Pediatric Res, 52: 377-81.
[19] Arai Y, Martin-Ruiz CM, Takayama M, et al (2015). Inflammation, but not telomere length, predicts successful ageing at extreme old age: a longitudinal study of semi-supercentenarians. EBioMedicine. 2(10): 1549-48.
[20] Dalgård C, Benetos A, Verhulst S, Labat C, Kark JD, et al (2015). Leukocyte telomere length dynamics in women and men: menopause vs age effects. Int J Epidemiol, 44(5): 1688-95.
[21] Njajou OT, Hsueh WC, Blackburn EH, Newman AB, Wu SH, Li R, Simonsick EM, Harris TM, Cummings SR, Cawthon RM (2009). Association between telomere length, specific causes of death, and years of healthy life in health, aging, and body composition, a population-based cohort study. J Gerontol A Biol Sci Med Sci, 64: 860-864.
[22] Sanders JL, Fitzpatrick AL, Boudreau RM, et al (2012). Leukocyte telomere length is associated with noninvasively measured age-related disease: the cardiovascular health study. J Gerontol, 67(4): 409-416.
[23] Bauman AE, Smith BJ (2000). Healthy ageing: what role can physical activity play? Med J Aust, 173: 88-90.
[24] Hassett AL, Epel E, Clauw DJ, Harris RE, Harte SE, Kairys A, Buyske S, Williams DA (2012). Pain is associated with short leukocyte telomere length in women with fibromyalgia. J Pain, 13: 959-969.
[25] Sibille KT, Langaee T, Burkley B, Gong Y, Glover TL, King C, et al (2012). Chronic pain, perceived stress, and cellular aging: an exploratory study. Mol Pain, 8: 12.
[26] Ludlow AT, Zimmerman JB, Witkowski S, Hearn JW, Hatfield BD, Roth SM (2008). Relationship between physical activity level, telomere length, and telomerase activity. Med Sci Sports Exerc, 40: 1764-1771.
[27] Denham J, Nelson CP, O’Brien BJ, Nankervis SA, Denniff M, et al (2013) Longer Leukocyte Telomeres Are Associated with Ultra-Endurance Exercise Independent of Cardiovascular Risk Factors. PLOS ONE, 8(7): e69377.
[28] Borghini A, Giardini G, Tonacci A, Mastorci F, Mercuri A, et al (2015). Chronic and acute effects of endurance training on telomere length. Mutagenesis, 30(5): 711-716.
[29] Cherkas LF, Hunkin JL, Kato BS, Richards JB, Gardner JPet al (2008). The association between physical activity in leisure time and leukocyte telomere length. Arch Intern Med, 168(2):154-8.
[30] Ludlow AT, Zimmerman JB, Witkowski S, Hearn JW, Hatfield BD, Roth SM (2008). Relationship between physical activity level, telomere length, and telomerase activity. Med Sci Sports Exerc, 40(10):1764-1771.
[31] Kim JH, Ko JH, Lee DC, Lim I, Bang H (2012). Habitual physical exercise has beneficial effects on telomere length in postmenopausal women. Menopause, 19(10):1109-15.134.
[32] Kadi F, Ponsot E, Piehl-Aulin K, Mackey A, Kjaer M, Oskarsson E, Holm L (2008). The effects of regular strength training on telomere length in human skeletal muscle. Med Sci Sports Ex, 40(1), 82-87.
[33] Østhus IBØ, Sgura A, Berardinelli F, Alsnes IV, Brønstad E, et al (2012). Telomere Length and Long-Term Endurance Exercise: Does Exercise Training Affect Biological Age? A Pilot Study. PLOS ONE, 7(12): e52769.
[34] Du M, Prescott J, Kraft P, et al (2012). Physical activity, sedentary behavior, and leukocyte telomere length in women. Am J Epidemiol, 175(5):414-422.
[35] Krauss J, Farzaneh-Far R, Puterman E, Na B, Lin J, Epel E, et al (2011). Physical fitness and telomere length in patients with coronary heart disease: findings from the Heart and Soul Study. PLoS One, 6:e26983.
[36] Mathur S, Ardestani A, Parker B, et al (2013). Telomere length and cardiorespiratory fitness in marathon runners. J InvMed, 61:613-615.
[37] Rae D, Vignaud A, Butler-Browne G, Thornell L, Sinclair-Smith C, et al (2010). Skeletal muscle telomere length in health, experienced, endurance runners. Eur J Appl Physiol, 109(2), 323-330.
[38] LaRocca TJ, Seals DR, Pierce GL (2010). Leukocyte telomere length is preserved with aging in endurance exercise-trained adults and related to maximal aerobic capacity. Mech Ageing Dev, 131(2):165-7.
[39] Arsenis Nicole C, You Tongjian, Ogawa Elisa F., Tinsley Grant M, Zuo Li (2017). Physical activity and telomere length: Impact of aging and potential mechanisms of action. Oncotarget, 8(27): 45008-45019.
[40] Werner C, Furster T, Widmann T, Poss J, Roggia C, Hanhoun M, et al (2009). Physical exercise prevents cellular senescence in circulating leukocytes and in the vessel wall. Circulation, 120: 2438-2447.
[41] Shin YA, Lee JH, Song W, Jun TW (2008). Exercise training improves the antioxidant enzyme activity with no changes of telomere length. Mech Ageing Dev, 129(5): 254-60.
[42] Bruunsgaard H, Jensen MS, Schjerling P, Halkjaer- Kristensen J, Ogawa K, Skinhoj P, Pedersen BK (1999). Exercise induces recruitment of lymphocytes with an activated phenotype and short telomeres in young and elderly humans. Life Sci, 65: 2623-2633.
[43] Werner C, Fürster T, Widmann T, Pöss J, Roggia C, Hanhoun M, Scharhag J, Büchner N, Meyer T, Kindermann W, Haendeler J, Böhm M, Laufs U (2009). Physical exercise prevents cellular senescence in circulating leukocytes and in the vessel wall. Circulation, 120(24):2438-47.
[44] You T, Arsenis NC, Disanzo BL, Lamonte MJ (2013). Effects of exercise training on chronic inflammation in obesity: current evidence and potential mechanisms. Sports Med, 43(4):243-56.
[45] Nimmo MA, Leggate M, Viana JL, King JA (2013). The effect of physical activity on mediators of inflammation. Diabetes Obes Metab, Suppl 3:51-60.
[46] Khan S, Chuturgoon AA, Naidoo DP (2012). Telomeres and atherosclerosis. Cardiovasc J Afr, 23(10):563-71.
[47] Zhang J, Rane G, Dai X, Shanmugam MK, Arfuso F, Samy RP, Lai MK, Kappei D, Kumar AP, Sethi G (2016). Ageing and the telomere connection: An intimate relationship with inflammation. Ageing Res Rev, 25:55-69.
[48] Radak Z, Chung HY, Koltai E, Taylor AW, Goto S (2008). Exercise, oxidative stress and hormesis. Ageing Res Rev, 7(1):34-42.
[49] Widlansky ME, Gokce N, Keaney JF Jr, Vita JA (2003). The clinical implications of endothelial dysfunction. J Am Coll Cardiol, 42: 1149-1160.
[50] Seals DR, Jablonski KL, Donato AJ (2011). Aging and vascular endothelial function in humans. Clin Sci, 120: 357-375.
[51] Keymel S, Schueller B, Sansone R, Wagstaff R, Steiner S, et al (2018). Clinical research
[52] Oxygen dependence of endothelium-dependent vasodilation: importance in chronic obstructive pulmonary disease. Arch Med Sci,14(2): 297-306.
[53] Feletou M. Te Endothelium, Part 1: Multiple Functions of the Endothelial Cells-Focus on Endothelium-Derived Vasoactive Mediators. San Rafael (CA): Morgan & Claypool Life Sciences, 2011.
[54] Moncada S, Higgs EA (1991). Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur J Clin Invest, 21(4): 361-74.
[55] Quyyumi AA, Dakak N, Andrews NP, Gilligan DM, Panza JA, Cannon RO 3rd (1995). Contribution of nitric oxide to metabolic coronary vasodilation in the human heart. Circulation, 92(3): 320-326.
[56] Otani H (2009). The role of nitric oxide in myocardial repair and remodeling. Antioxid Redox Signal, 11(8): 1913-28.
[57] Loke KE, Messina EJ, Shesely EG, Kaley G, Hintze TH (2001). Potential Role of eNOS in the Therapeutic Control of Myocardial Oxygen Consumption by ACE Inhibitors and Amlodipine. Cardiovasc Res, 49(1): 86-93.
[58] Vecoli C, Andreassi MG, Liga R, Colombo MG, Coceani M, Carpeggiani C, L'Abbate A, Neglia D (2012). T(-786)→C polymorphism of the endothelial nitric oxide synthase gene is associated with insulin resistance in patients with ischemic or non ischemic cardiomyopathy. BMC Med Genet, 13: 92.
[59] Yoon Y, Song J, Hong SH, Kim JQ (2001). Plasma nitric oxide concentrations and nitric oxide synthase gene polymorphisms in coronary artery disease. Clin Chem, 46(10):1626-30.
[60] Colombo MG, Andreassi MG, Paradossi U, Botto N, Manfredi S, Masetti S, et al. (2002) Evidence for association of a common variant of the endothelial nitric oxide synthase gene (Glu298--> Asp polymorphism) to the presence, extent, and severity of coronary artery disease. Heart, 87(6): 525-8.
[61] Yao YS, Chang WW, Jin YL, He LP (2013). An updated meta-analysis of endothelial nitric oxide synthase gene: three well-characterized polymorphisms with ischemic stroke. Gene, 528(2): 84-92.
[62] Monti LD, Barlassina C, Citterio L, Galluccio E, Berzuini C, Setola E, et al (2003). Endothelial nitric oxide synthase polymorphisms are associated with type 2 diabetes and the insulin resistance syndrome. Diabetes, 52(5): 1270-5.
[63] Ohtoshi K, Yamasaki Y, Gorogawa S, Hayaishi-Okano R, Node K, et al (2002). Association of (-)786T-C mutation of endothelial nitric oxide synthase gene with insulin resistance Diabetologia, 45(11): 1594-601.
[64] Yao L, Fang F, Zhong Y, Yu L (2010). The association between two polymorphisms of eNOS and breast cancer risk: a meta-analysis. Breast Cancer Res Treat, 124(1): 223-7.
[65] Schini-Kerth VB, Auger C, Etienne-Selloum N, Chataigneau T (2010). Polyphenol-induced endotheliumdependent relaxations role of NO and EDHF. Adv Pharmacol, 60: 133-175.
[66] Seals DR, Walker AE, Pierce GL, Lesniewski LA (2009). Habitual exercise and vascular ageing. J Physiol, 587: 5541-5549.
[67] Hambrecht R, Adams V, Erbs S, Linke A, Kränkel N, Shu Y, et al (2003). Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase. Circulation, 107(25):3152-8.
[68] Adams V, Reich B, Uhlemann M, Niebauer J (2017). Molecular effects of exercise training in patients with cardiovascular disease: focus on skeletal muscle, endothelium, and myocardium. Am J Physiol Heart Circ Physiol, 313(1):H72-H88.
[69] DeSouza CA, Shapiro LF, Clevenger CM, Dinenno FA, Monahan KD, Tanaka H, Seals DR (2000). Regular aerobic exercise prevents and restores age-related declines in endothelium-dependent vasodilation in healthy men Circulation, 102(12): 1351-1357.
[70] Qi H, Yang S, Zhang L (2017). Neutrophil Extracellular Traps and Endothelial Dysfunction in Atherosclerosis and Thrombosis. Front Immunol, 8:928.
[71] Lowe GD (2008). Common risk factors for both arterial and venous thrombosis. Br J Haematol,140: 488-95.
[72] Laukkanen JA, Kurl S, Salonen R, Rauramaa R, Salonen JT (2004). The predictive value of cardiorespiratory fitness for cardiovascular events in men with various risk profiles: a prospective population-based cohort study. Eur Heart J, 25(16): 1428-37.
[73] Wagner A, Simon C, Evans A, Ferrieres J, Montaye M, et al (2002). Physical activity and coronary event incidence in Northern Ireland and France: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation, 105: 2247-2252.
[74] Soga Y, Yokoi H, Amemiya K, Iwabuchi M, Nobuyoshi M (2011). Safety and efficacy of exercise training after coronary stenting in patients with stable coronary artery disease. Circ J, 75: 2379-2386.
[75] Evensen LH, Brækkan SK, Hansen JB (2018). Regular Physical Activity and Risk of Venous Thromboembolism. Semin Thromb Hemost, 44(8):765-779.
[76] Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, et al (2003). National high blood pressure education program coordination committee. seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure. Hypertension, 42: 1206-1252.
[77] Pescatello LS, Franklin BA, Fagard R, Farqijar WB, Kelley GA, Ray CA (2004). Exercise and hypertension: American College of Sports Medicine, Position Stand. Med Sci Sports Exerc, 36: 533-552.
[78] Sabbahi A, Arena R, Elokda A, Phillips SA (2016). Exercise and Hypertension: Uncovering the Mechanisms of Vascular Control. Prog Cardiovasc Dis, 59(3): 226-234.
[79] Thijssen DHJ, Maiorana A, Green DJ (2015). Aerobic exercise training: Effects on vascular function and Structure. In: Linda S.Pescatello, editor. The effect of exercise on hypertension - from cells to physiological systems. Switzerland: Springer International Publishing, 105-135.
[80] Gielen S, Schuler G, Adams V (2010). Cardiovascular effects of exercise training: molecular mechanisms. Circulation, 122(12):1221-38.
[81] Jurva JW, Phillips SA, Syed AQ, Syed AY, Pitt S, Weaver A, Gutterman DD (2006). The effect of exertional hypertension evoked by weightlifting on vascular endothelial function. J Am Coll Cardiol, 48(3):588-9.
[82] Hambrecht R, Adams V, Erbs S, Linke A, Kränkel N, et al (2003). Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase. Circulation, 107(25):3152-8.
[83] Van Guilder GP, Westby CM, Greiner JJ, Stauffer BL, DeSouza CA (2007). Endothelin-1 vasoconstrictor tone increases with age in healthy men but can be reduced by regular aerobic exercise. Hypertension, 50(2):403-9.
[84] Adams V, Linke A, Kränkel N, Erbs S, Gielen S, Möbius-Winkler S, et al (2005). Impact of regular physical activity on the NAD(P)H oxidase and angiotensin receptor system in patients with coronary artery disease. Circulation, 111(5):555-62.
[85] Spence AL, Carter HH, Naylor LH, Green DJ (2013). A prospective randomized longitudinal study involving 6 months of endurance or resistance exercise. Conduit artery adaptation in humans. J Physiol, 591(5):1265-75.
[86] Tanaka H, Dinenno FA, Monahan KD, Clevenger CM, DeSouza CA, Seals DR (2000). Aging, habitual exercise, and dynamic arterial compliance. Circulation, 102(11):1270-5.
[87] Laterza MC, de Matos LD, Trombetta IC, Braga AM, Roveda F, Alves MJ, et al (2007). Exercise training restores baroreflex sensitivity in never-treated hypertensive patients. Hypertension, 49(6):1298-306.
[88] Cornelissen VA, Fagard RH (2005). Effects of endurance training on blood pressure, blood pressure-regulating mechanisms, and cardiovascular risk factors. Hypertension, 46(4): 667-675.
[89] Cornelissen VA, Smart NA (2013). Exercise Training for Blood Pressure: A Systematic Review and Meta ‐ analysis. J Am Heart Assoc, 2(1): e004473.
[90] Badrov MB, Freeman SR, Zokvic MA, Millar PJ, McGowan CL (2016). Isometric exercise training lowers resting blood pressure and improves local brachial artery flow - mediated dilation equally in men and women. Eur J Appl Physiol, 116(7): 1289-96.
[91] Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. (2018). ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J, 39(33):3021-3104.
[92] Koh KK, Quon MJ, Han SH, et al (2008). Simvastatin improves flow - mediated dilation, but reduces adiponectin levels and insulin sensitivity in hypercholesterolemic patients. Diabetes Care, 31: 776-82.
[93] Koh KK, Quon MJ, Han SH, Lee Y, Kim SJ, Shin EK (2010). Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients. J Am Coll Cardiol, 55: 1209-16.
[94] Koh KK, Sakuma I, Shimada K, Hayashi T, Quon MJ (2017). Combining potent statin therapy with other drugs to optimize simultaneous cardiovascular and metabolic benefits while minimizing adverse events. Korean Circ J, 47(4): 432-439.
[95] Fiuza-Luces C, Garatachea N, Berger NA, Lucia A (2013). Exercise is the real polypill. Physiology (Bethesda), 28(5): 330-58.
[96] Holten MK, Zacho M, Gaster M, Juel C, Wojtaszewski JF, Dela F (2004). Strength training increases insulin-mediated glucose uptake, GLUT4 content, and insulin signaling in skeletal muscle in patients with type 2 diabetes. Diabetes, 53(2):294-305.
[97] Furukawa N, Ongusaha P, Jahng WJ, Araki K, Choi CS, Kim HJ, et al (2005). Role of Rho-kinase in regulation of insulin action and glucose homeostasis. Cell Metab, 2(2):119-29.
[98] Dela F, Handberg A, Mikines KJ, Vinten J, Galbo H (1993). GLUT 4 and insulin receptor binding and kinase activity in trained human muscle. J Physiol, 469:615-24.
[99] Coggan AR, Spina RJ, Kohrt WM, Holloszy JO (1993). Effect of prolonged exercise on muscle citrate concentration before and after endurance training in men. Am J Physiol, 264(2 Pt 1):E215-20.
[100] Dela F, Ploug T, Handberg A, Petersen LN, Larsen JJ, Mikines KJ, Galbo H (1994). Physical training increases muscle GLUT4 protein and mRNA in patients with NIDDM. Diabetes, 43(7):862-5.
[101] van Dieren S, Beulens JW, van der Schouw YT, Grobbee DE, Neal B (2010). The global burden of diabetes and its complications: an emerging pandemic. Eur J Cardiovasc Prev Rehabil, 17(suppl 1): 3-8.
[102] American Diabetes Association. Standards of medical care in diabetes -2013. Diabetes Care 2013; 36(suppl 1): 11-66.
[103] Chew EY, Ambrosius WT, Davis MD, et al. (2010). Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med, 363(3): 233-244.
[104] Umpierre D, Ribeiro PA, Kramer CK, Leitao CB, Zucatti AT, Azevedo MJ, et al (2011). Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta - analysis. JAMA, 305: 1790-1799.
[105] Hirst JA, Farmer AJ, Raghib A, Roberts NW, Stevens RJ (2012). Quantifying the effect of metformin treatment and dose on glycemic control. Diabetes Care, 35: 446-454.
[106] Cheng D, Fei Y, Liu Y, et al. (2014). Efficacy and safety of dipeptidyl peptidase-4 inhibitors in type 2 diabetes mellitus patients with moderate to severe renal impairment: a systematic review and meta-analysis. PLoS ONE, 9(10):e111543.
[107] Handrean S, Safwaan A, Mohammad JB, Ho JH, Schofield JD, Kwok S, et al (2018). Hypercholesterolaemia - practical information for non-specialists. Arch Med Sci, 14, 1: 1-21.
[108] National Cholesterol Education Program. National Heart Lung and Blood Institute (2002). National Institutes of Health Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation, 106: 3143-3421.
[109] Kelley GA, Kelley KS (2012). Comparison of aerobic exercise, diet or both on lipids and lipoproteins in adults: a meta-analysis of randomized controlled trials. Clin Nutr, 31(2): 156-167.
[110] Kobayashi J, Nohara A, Kawashiri MA, Inazu A, Koizumi J, Nakajima K, Mabuchi H (2007). Serum lipoprotein lipase mass: clinical significance of its measurement. Clin Chim Acta, 378:7-12.
[111] Zhang JQ, Smith B, Langdon MM, Messimer HL, Sun GY, Cox RH, et al. (2002). Changes in LPLa and reverse cholesterol transport variables during 24-h postexercise period. Am J Physiol Endocrinol Metab, 283(2):E267-74.
[112] Butcher LR, Thomas A, Backx K, Roberts A, Webb R, Morris K (2008). Low-intensity exercise exerts beneficial effects on plasma lipids via PPARgamma. Med Sci Sports Exerc, 40(7):1263-70.
[113] Kelley GA, Kelley KS, Roberts S, Haskell W (2012). Comparison of aerobic exercise, diet or both on lipids and lipoproteins in adults: a meta-analysis of randomized controlled trials. Clin Nutr, 31: 156-167.
[114] Tiainen S, Kiviniemi A, Hautala A, Huikuri H, Ukkola O, Tokola K, et al (2018). Effects of a Two-Year Home-Based Exercise Training Program on Oxidized LDL and HDL Lipids in Coronary Artery Disease Patients with and without Type-2 Diabetes. Antioxidants (Basel), 16:7(10).
[115] Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, et al (2010). Efficacy and safety of more intensive lowering of LDL cholesterol: a metaanalysis of data from 170,000 participants in 26 randomised trials. Lancet, 376: 1670-1681.
[116] Adams SP, Tsang M, Wright JM (2012). Lipid lowering efficacy of atorvastatin. Cochrane Database Syst Rev, 12: CD008226.
[117] Blair SN, LaMonte MJ, Nichaman MZ (2004). The evolution of physical activity recommendations: how much is enough? Am J Clin Nutr, 79: 913-920.
[118] Ploeger HE, Takken T, de Greef MH, Timmons BW (2009). The effects of acute and chronic exercise on inflammatory markers in children and adults with a chronic inflammatory disease: a systematic review. Exerc Immunol Rev, 15:6-41.
[119] World Health Organization (2017). The top 10 causes of death. www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death.
[120] Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JDet al. (2012). Heart disease and stroke statistics - 2012 update: a report from the American Heart Association. Circulation, 125: e2-e220.
[121] Kodama S, Saito K, Tanaka S, Maki M, Yachi Y, Asumi M, et al (2009). Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA, 301: 2024-2035.
[122] Lee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT. Lancet Physical Activity Series Working G (2012). Effect of physical inactivity on major non - communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet, 380: 219-229.
[123] Garatachea N, Santos-Lozano A, Sanchis-Gomar F, Pareja- Galeano H, Emanuele E, Lucia A (2014). Former elite athletes live longer than the general population: a meta-analysis. Mayo Clin Proc, 89(9): 1195-1200.
[124] Ruiz JR, Moran M, Arenas J, Lucia A (2011). Strenuous endurance exercise improves life expectancy: it’s in our genes. Br J Sports Med, 45: 159-161.
[125] Pedersen BK, Saltin B (2006). Evidence for prescribing exercise as therapy in chronic disease. Scand. J Med Sci Sports, 16(Suppl. 1), 3-63.
[126] Andersen K, Farahmand B, Ahlbom A, et al (2013). Risk of arrhythmias in 52 755 long - distance cross - country skiers: a cohort study. Eur Heart J, 34(47): 3624-3631.
[127] Drca N, Wolk A, Jensen-Urstad M, Larsson SC (2014). Atrial fibrillation is associated with different levels of physical activity levels at different ages in men. Heart, 100(13): 1037-1042.
[128] Mozaffarian D, Furberg CD, Psaty BM, Siscovick D (2008). Physical activity and incidence of atrial fibrillation in older adults: the cardiovascular health study. Circulation, 118(8):800-807.
[129] Roberts WO, Stovitz SD (2013). Incidence of sudden cardiac death in Minnesota high school athletes 1993-2012 screened with a standardized pre-participation evaluation. J Am Coll Cardiol, 62(14): 1298-301.
[130] O'Keefe JH, Franklin B, Lavie CJ (2014). Exercising for health and longevity vs peak performance: different regimens for different goals. Mayo Clin Proc, 89(9): 1171-5.
[131] Vuori IM, Lavie CJ, Blair SN (2013) Physical activity promotion in the health care system. Mayo Clin Proc, 88(12): 1446-61.
[132] Piercy KL, Troiano RP, Ballard RM, Carlson SA, Fulton JE, Galuska DA, et al. (2018). The Physical Activity Guidelines for Americans. JAMA, 20;320(19):2020-2028.
[133] Schmitz KH, Courneya KS, Matthews C, et al. (2010). American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc, 42: 1409-26.
[134] Williams P, Thompson P (2014). Increased cardiovascular disease mortality from excessive exercise in heart attack survivors. Mayo Clin Proc, 89(9): 1187-1194.
[135] Lee D-C, Pate RR, Lavie CJ, Sui X, Church TS, Blair SN (2014). Leisuretime running reduces all-cause and cardiovascular mortality risk. J Am Coll Cardiol, 64(5): 472-481.
[136] Seals DR, Dinenno FA (2004). Collateral damage: cardiovascular consequences of chronic sympathetic activation with human aging. Am J Physiol Heart Circ Physiol, 287: 1895-1905.
[137] Nolan RP, Jong P, Barry-Bianchi SM, Tanaka TH, Floras JS (2008). Effects of drug, biobehavioral and exercise therapies on heart rate variability in coronary artery disease: a systematic review. Eur J Cardiovasc Prev Rehabil, 15: 386-396.
[138] Jensen MT, Suadicani P, Hein HO, Gyntelberg F (2013). Elevated resting heart rate, physical fitness and all-cause mortality: a 16-year follow-up in the Copenhagen Male Study. Heart, 99: 882-887.
[139] Rosiek A, Maciejewska NF, Leksowski K, Rosiek-Kryszewska A, Leksowski L (2015). Effect of television on obesity and excess of weight and consequences of health. Int J Environ Res Public Health, 12: 9408-9426.
[140] Gronek P (2016). My Laboratory of Arts. Wydawnictwo AWF [in Polish]
[141] Klados MA, Styliadis C, Frantzidis CA, Paraskevopoulos E, Bamidis PD (2016). Beta - Band functional connectivity is reorganized in mild cognitive impairment after combined computerized physical and cognitive training. Front Neurosci, 10: 55.
[1] Campanini Marcela Z., Mesas Arthur E., Carnicero-Carreño Jose Antonio, Rodríguez-Artalejo Fernando, Lopez-Garcia Esther. Duration and Quality of Sleep and Risk of Physical Function Impairment and Disability in Older Adults: Results from the ENRICA and ELSA Cohorts[J]. Aging and disease, 2019, 10(3): 557-569.
[2] Cho Kyoungjoo. Emerging Roles of Complement Protein C1q in Neurodegeneration[J]. Aging and disease, 2019, 10(3): 652-663.
[3] Gourmelon Robin, Donadio-Andréi Sandrine, Chikh Karim, Rabilloud Muriel, Kuczewski Elisabetta, Gauchez Anne-Sophie, Charrié Anne, Brard Pierre-Yves, Andréani Raphaëlle, Bourre Jean-Cyril, Waterlot Christine, Guédel Domitille, Mayer Anne, Disse Emmanuel, Thivolet Charles, Boullay Hélène Du, Falandry Claire, Gilbert Thomas, François-Joubert Anne, Vignoles Antoine, Ronin Catherine, Bonnefoy Marc. Subclinical Hypothyroidism: is it Really Subclinical with Aging?[J]. Aging and disease, 2019, 10(3): 520-529.
[4] Jin Kunlin. A Microcirculatory Theory of Aging[J]. Aging and disease, 2019, 10(3): 676-683.
[5] Shetty Ashok K., Upadhya Raghavendra, Madhu Leelavathi N., Kodali Maheedhar. Novel Insights on Systemic and Brain Aging, Stroke, Amyotrophic Lateral Sclerosis, and Alzheimer’s Disease[J]. Aging and disease, 2019, 10(2): 470-482.
[6] Lana Alberto, Struijk Ellen A., Arias-Fernandez Lucía, Graciani Auxiliadora, Mesas Arthur E., Rodriguez-Artalejo Fernando, Lopez-Garcia Esther. Habitual Meat Consumption and Changes in Sleep Duration and Quality in Older Adults[J]. Aging and disease, 2019, 10(2): 267-277.
[7] Murtha Lucy A., Morten Matthew, Schuliga Michael J., Mabotuwana Nishani S., Hardy Sean A., Waters David W., Burgess Janette K., Ngo Doan TM., Sverdlov Aaron L., Knight Darryl A., Boyle Andrew J.. The Role of Pathological Aging in Cardiac and Pulmonary Fibrosis[J]. Aging and disease, 2019, 10(2): 419-428.
[8] Chung Hae Young, Kim Dae Hyun, Lee Eun Kyeong, Chung Ki Wung, Chung Sangwoon, Lee Bonggi, Seo Arnold Y., Chung Jae Heun, Jung Young Suk, Im Eunok, Lee Jaewon, Kim Nam Deuk, Choi Yeon Ja, Im Dong Soon, Yu Byung Pal. Redefining Chronic Inflammation in Aging and Age-Related Diseases: Proposal of the Senoinflammation Concept[J]. Aging and disease, 2019, 10(2): 367-382.
[9] Sarkar Saumyendra N., Russell Ashley E., Engler-Chiurazzi Elizabeth B., Porter Keyana N., Simpkins James W.. MicroRNAs and the Genetic Nexus of Brain Aging, Neuroinflammation, Neurodegeneration, and Brain Trauma[J]. Aging and disease, 2019, 10(2): 329-352.
[10] Cyprien Fabienne, Courtet Philippe, Maller Jerome, Meslin Chantal, Ritchie Karen, Ancelin Marie-Laure, Artero Sylvaine. Increased Serum C-reactive Protein and Corpus Callosum Alterations in Older Adults[J]. Aging and disease, 2019, 10(2): 463-469.
[11] Dong Liu,Liqun Xu,Xiaoyan Zhang,Changhong Shi,Shubin Qiao,Zhiqiang Ma,Jiansong Yuan. Snapshot: Implications for mTOR in Aging-related Ischemia/Reperfusion Injury[J]. Aging and disease, 2019, 10(1): 116-133.
[12] Michael G. Flynn,Melissa M. Markofski,Andres E. Carrillo. Elevated Inflammatory Status and Increased Risk of Chronic Disease in Chronological Aging: Inflamm-aging or Inflamm-inactivity?[J]. Aging and disease, 2019, 10(1): 147-156.
[13] Tingting Sui,Di Liu,Tingjun Liu,Jichao Deng,Mao Chen,Yuanyuan Xu,Yuning Song,Hongsheng Ouyang,Liangxue Lai,Zhanjun Li. LMNA-mutated Rabbits: A Model of Premature Aging Syndrome with Muscular Dystrophy and Dilated Cardiomyopathy[J]. Aging and disease, 2019, 10(1): 102-115.
[14] Yu-Wen Huang, Ming-Fu Chiang, Che-Sheng Ho, Pi-Lien Hung, Mei-Hsin Hsu, Tsung-Han Lee, Lichieh Julie Chu, Hsuan Liu, Petrus Tang, Wailap Victor Ng, Dar-Shong Lin. A Transcriptome Study of Progeroid Neurocutaneous Syndrome Reveals POSTN As a New Element in Proline Metabolic Disorder[J]. Aging and disease, 2018, 9(6): 1043-1057.
[15] Manuel Scimeca, Federica Centofanti, Monica Celi, Elena Gasbarra, Giuseppe Novelli, Annalisa Botta, Umberto Tarantino. Vitamin D Receptor in Muscle Atrophy of Elderly Patients: A Key Element of Osteoporosis-Sarcopenia Connection[J]. Aging and disease, 2018, 9(6): 952-964.
Viewed
Full text


Abstract

Cited

  Shared   
Copyright © 2014 Aging and Disease, All Rights Reserved.
Address: Aging and Disease Editorial Office 3400 Camp Bowie Boulevard Fort Worth, TX76106 USA
Fax: (817) 735-0408 E-mail: editorial@aginganddisease.org
Powered by Beijing Magtech Co. Ltd